Acadia Pharmaceuticals Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ACAD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

205,433

Value ($000)

5,487

Weight

0.0%

2013 Q4 - 2025 Q4 (26 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	5,487	0.0%	205,433	12/31/2025
2025 Q3	11/14/2025	4,505	0.0%	211,115	9/30/2025
2025 Q2	8/14/2025	7,396	0.0%	342,882	6/30/2025
2025 Q1	5/19/2025	4,170	0.0%	251,056	3/31/2025
2024 Q4	2/14/2025	4,021	0.0%	219,125	12/31/2024
2024 Q3	11/14/2024	2,918	0.0%	189,739	9/30/2024
2024 Q2	8/14/2024	3,536	0.0%	217,595	6/30/2024
2024 Q1	5/15/2024	2,207	0.0%	119,343	3/31/2024
2023 Q4	2/14/2024	3,831	0.0%	122,348	12/31/2023
2023 Q3	11/13/2023	2,475	0.0%	118,743	9/30/2023
2023 Q2	8/11/2023	2,383	0.0%	126,615	6/30/2023
2023 Q1	5/15/2023	2,383	0.0%	126,615	3/31/2023
2022 Q3	11/14/2022	2,016	0.0%	123,201	9/30/2022
2022 Q2	8/12/2022	8,659	0.0%	614,537	6/30/2022
2022 Q1	5/16/2022	13,862	0.0%	572,345	3/31/2022
2021 Q4	2/14/2022	12,650	0.0%	541,993	12/31/2021
2021 Q3	11/15/2021	7,704	0.0%	463,808	9/30/2021
2021 Q2	8/16/2021	11,828	0.0%	484,937	6/30/2021
2021 Q1	5/14/2021	10,414	0.0%	403,625	3/31/2021
2020 Q4	3/1/2021	30,731	0.0%	574,845	12/31/2020
2020 Q3	11/13/2020	24,326	0.0%	589,726	9/30/2020
2020 Q2	8/14/2020	44,576	0.0%	919,654	6/30/2020
2020 Q1	5/15/2020	32,769	0.0%	775,602	3/31/2020
2019 Q4	2/14/2020	36,825	0.0%	860,797	12/31/2019
2014 Q1	5/23/2014	789	0.0%	32,431	3/31/2014
2013 Q4	1/31/2014	505	0.0%	20,200	12/31/2013